In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Michele Senni
Speaker
Michele Senni
Michele Senni Michele Senni

Ospedale Papa Giovanni XXIII, Bergamo (Italy)

Speciality : Chronic Heart Failure

USC Cardiology 1 - Heart Failure and Transplantation, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy Michele Senni is Director of the USC Cardiology 1 - Heart Failure and Transplantation at the Papa Giovanni XXIII Hospital in Bergamo, Italy. He has been a Fellow of the Mayo Clinic, of the European Society of Cardiology (since 2000) and of the ANMCO (Associazione Nazionale Medici Cardiologi Ospedalieri since 2001), and has served, as Global Lead Investigator, National Coordinator and Principal Investigator of numerous clinical trials, including PARADIGM, PARAGON, TITRATION, EMPHASIS-HF, RED HF. Dr Senni was Chairman of Heart Failure Working Group of ANMCO in 2009–2010. Dr Senni has a wide range of research interests including various aspects of left-ventricular remodeling and heart failure. Some of his more recent publications have concerned the role of biomarkers for cardiac structure phenotyping in heart failure, the prognostic stratification in stable HF patients and targeted s

42 presentations from this speaker

Device therapies in Heart failure continuum of care: time to treat!

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : J Bax (Leiden,NL), M Senni (Bergamo,IT), A Chow (London,GB), R Von Bardeleben (Mainz,DE), JJ Brugts (Rotterdam,NL), A Coats (Warwickshire,GB)
  • Sponsored by Abbott

Future of HFpEF: what's coming?

Event : ESC Congress 2020

  • Session : Expert Advice - How Well Do We Know HFpEF?
  • Speaker : M Senni (Bergamo,IT)

HF treatment: what do our patients expect?

Event : ESC Congress 2020

  • Session : Making essential treatment choices in heart failure
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Introduction ; Adressing Complexities of HF treatment.

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : J Bax (Leiden,NL), M Senni (Bergamo,IT)
  • Sponsored by Abbott

Making essential treatment choices in heart failure - Sponsored by Novartis Pharma AG.

Event : ESC Congress 2020

  • Session : Making essential treatment choices in heart failure
  • Speaker : A Coats (Warwickshire,GB), M Senni (Bergamo,IT), J Januzzi (Boston,US), CS Lam (Singapore,SG)
  • Sponsored by Novartis Pharma AG

Treating Valvular Diseases in Heart Failure: Time is key.

Event : ESC Congress 2020

  • Session : Mitral and Tricuspid regurgitation in Heart Failure: Time to treat
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by ABBOTT

What is on the horizon to help us address unmet needs?

Event : ESC Congress 2020

  • Session : Making essential treatment choices for heart failure patients: Experts on the spot
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

COAPT & MitraFR results presentation.

Event : EHRA 2019

  • Session : Transcatheter Mitral Valve Repair (TMVR) in Functional Mitral Regurgitation (FMR) : time to treat!
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott

Heart failure with preserved ejection fraction: how to further improve patient outcomes?

Event : ESC Congress 2019

  • Session : Heart failure with preserved ejection fraction
  • Speaker : M Senni (Bergamo,IT)

Heart rate as a prognostic risk factor and target in chronic heart failure

Event : ESC Congress 2019

  • Session : The heart failure patient's journey: key learning and objectives
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Servier

How to achieve the optimisation we aim for.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis

Panel discussion - Making critical choices for patients at the right time.

Event : Heart Failure 2019

  • Session : Making critical choices for patients at the right time – Join the discussion
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Panel discussion - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Pathophysiology.

Event : Heart Failure 2019

  • Session : HFpEF: current diagnosis and management
  • Speaker : M Senni (Bergamo,IT)

Therapeutic approach to HFpEF.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : J Bauersachs (Hannover,DE), P Seferovic (Belgrade,RS), M Senni (Bergamo,IT)

Therapeutic approaches in HFpEF: current and future concepts.

Event : ESC Congress 2019

  • Session : Update on novel therapeutic approaches in heart failure
  • Speaker : M Senni (Bergamo,IT)
  • Heart Failure Association (HFA)

Treating Functional Mitral Regurgitation (FMR) in HF: What COAPT & MitraFR tell us. Part 1.

Event : EHRA 2019

  • Session : Treating heart failure (HF) with device therapies : what’s new?
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott

Understanding the role of comorbidities in HFpEF

Event : ESC Congress 2019

  • Session : Expert Advice - Focus on heart failure with preserved ejection fraction (HFpEF)
  • Speaker : M Senni (Bergamo,IT)

Update on the management of HFpEF.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : J Bauersachs (Hannover,DE), P Seferovic (Belgrade,RS), M Senni (Bergamo,IT)

Why should we treat functional mitral regurgitation in heart failure.

Event : Heart Failure 2019

  • Session : Functional mitral regurgitation in heart failure: time to treat!
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott

Functional mitral regurgitation in heart failure.

Event : Heart Failure 2018

  • Session : Treating Functional Mitral Regurgitation (FMR) in heart failure: time for evidence!
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott Structural Heart

Functionnal mitral regurgitation: all you need to know.

Event : ESC Congress 2018

  • Session : Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott

The dilemma of treating patients following hospitalization for acute decompensated heart failure.

Event : Heart Failure 2018

  • Session : Resolving dilemmas in the treatment of heart failure
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis

Why mitral regurgitation is important for the electrophysiologist.

Event : EHRA 2018

  • Session : Treating mitral regurgitation in heart failure: what is new for the electrophysiologist?
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by ABBOTT STRUCTURAL HEART

A 59 year old man with hypertension, LVH and dyspnea on exertion.

Event : ESC Congress 2017

  • Session : The hypertensive heart
  • Speaker : M Senni (Bergamo,IT)

Severe mitral regurgitation: what are we talking about?

Event : ESC Congress 2017

  • Session : Transcatheter mitral valve repair therapy: adding life to years... And more!
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott Vascular

Ask the experts: your questions on optimizing heart failure management and the future of new treatments answered.

Event : Heart Failure 2016

  • Session : Ask the experts: your questions on optimizing heart failure management and the future of new treatments answered
  • Speaker : JJV McMurray (Glasgow,GB), B Pieske (Berlin,DE), F Ruschitzka (Zurich,CH), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Benefits of a multidisciplinary approach when optimizing current and integrating new heart failure treatments for improved outcomes: panel discussion.

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : F Ruschitzka (Zurich,CH), R Hobbs (Oxford,GB), T Jaarsma (Norrkoping,SE), J Riley (London,GB), B Pieske (Berlin,DE), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Optimising current and integrating new treatments: experience from clinical practice (part B).

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Summary of key learning points and close.

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : F Ruschitzka (Zurich,CH), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Welcome and introduction.

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : F Ruschitzka (Zurich,CH), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Welcome and introduction.

Event : ESC Congress 2016

  • Session : Optimizing outcomes in patients with heart failure with reduced ejection fraction: evidence and clinical experience sharing
  • Speaker : JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Why should we treat mitral regurgitation?

Event : Heart Failure 2016

  • Session : Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott Vascular

Mitral regurgitation kills: the urgency to diagnose and treat.

Event : ESC Congress 2015

  • Session : Transcatheter Mitral Valve Repair (TMVR): how to optimize mitral regurgitation treatment
  • Speaker : M Senni (Bergamo,IT)
  • Sponsored by Abbott Vascular

State of the Art in heart failure and comorbidities.

Event : ESC Congress 2015

  • Session : Co-morbidities and heart failure prognosis
  • Speaker : M Senni (Bergamo,IT)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are